The Collaborative Institutional Training Initiative (CITI Program) Good Clinical Practice (GCP-R3) training certificates have been updated, effective April 1, 2026.
This update aims to clearly indicate alignment with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH E6-R3) GCP Investigator Site Training and ensure the training meets TransCelerate’s minimum criteria, supporting mutual recognition among trial sponsors.
This applies to GCP Refresher (English and French), and GCP Canada (English and French). Researchers and research personnel are advised to save or print new certificates to ensure they reflect the updated statement.
For more information about compliance training requirements, visit the Compliance and Training for Human Participants Research webpage.